PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
SBRA vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between SBRA and SPY is 0.42, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

SBRA vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sabra Health Care REIT, Inc. (SBRA) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

-5.00%0.00%5.00%10.00%15.00%20.00%AugustSeptemberOctoberNovemberDecember2025
6.15%
7.12%
SBRA
SPY

Key characteristics

Sharpe Ratio

SBRA:

1.25

SPY:

2.03

Sortino Ratio

SBRA:

1.75

SPY:

2.71

Omega Ratio

SBRA:

1.22

SPY:

1.38

Calmar Ratio

SBRA:

1.18

SPY:

3.09

Martin Ratio

SBRA:

5.90

SPY:

12.94

Ulcer Index

SBRA:

4.89%

SPY:

2.01%

Daily Std Dev

SBRA:

23.05%

SPY:

12.78%

Max Drawdown

SBRA:

-74.93%

SPY:

-55.19%

Current Drawdown

SBRA:

-12.13%

SPY:

-2.14%

Returns By Period

In the year-to-date period, SBRA achieves a -1.85% return, which is significantly lower than SPY's 1.14% return. Over the past 10 years, SBRA has underperformed SPY with an annualized return of 1.55%, while SPY has yielded a comparatively higher 13.38% annualized return.


SBRA

YTD

-1.85%

1M

-2.13%

6M

6.15%

1Y

30.55%

5Y*

3.30%

10Y*

1.55%

SPY

YTD

1.14%

1M

-1.98%

6M

7.12%

1Y

26.42%

5Y*

14.07%

10Y*

13.38%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

SBRA vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SBRA
The Risk-Adjusted Performance Rank of SBRA is 8181
Overall Rank
The Sharpe Ratio Rank of SBRA is 8484
Sharpe Ratio Rank
The Sortino Ratio Rank of SBRA is 7878
Sortino Ratio Rank
The Omega Ratio Rank of SBRA is 7575
Omega Ratio Rank
The Calmar Ratio Rank of SBRA is 8383
Calmar Ratio Rank
The Martin Ratio Rank of SBRA is 8585
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 8383
Overall Rank
The Sharpe Ratio Rank of SPY is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 8080
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 8282
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 8383
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

SBRA vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Sabra Health Care REIT, Inc. (SBRA) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for SBRA, currently valued at 1.25, compared to the broader market-2.000.002.001.252.03
The chart of Sortino ratio for SBRA, currently valued at 1.75, compared to the broader market-4.00-2.000.002.004.001.752.71
The chart of Omega ratio for SBRA, currently valued at 1.22, compared to the broader market0.501.001.502.001.221.38
The chart of Calmar ratio for SBRA, currently valued at 1.18, compared to the broader market0.002.004.006.001.183.09
The chart of Martin ratio for SBRA, currently valued at 5.90, compared to the broader market-30.00-20.00-10.000.0010.0020.005.9012.94
SBRA
SPY

The current SBRA Sharpe Ratio is 1.25, which is lower than the SPY Sharpe Ratio of 2.03. The chart below compares the historical Sharpe Ratios of SBRA and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.001.502.002.503.003.50AugustSeptemberOctoberNovemberDecember2025
1.25
2.03
SBRA
SPY

Dividends

SBRA vs. SPY - Dividend Comparison

SBRA's dividend yield for the trailing twelve months is around 7.06%, more than SPY's 1.19% yield.


TTM20242023202220212020201920182017201620152014
SBRA
Sabra Health Care REIT, Inc.
7.06%6.93%8.41%9.65%8.86%7.77%8.43%10.92%9.22%6.84%7.91%4.97%
SPY
SPDR S&P 500 ETF
1.19%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

SBRA vs. SPY - Drawdown Comparison

The maximum SBRA drawdown since its inception was -74.93%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for SBRA and SPY. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%AugustSeptemberOctoberNovemberDecember2025
-12.13%
-2.14%
SBRA
SPY

Volatility

SBRA vs. SPY - Volatility Comparison

Sabra Health Care REIT, Inc. (SBRA) has a higher volatility of 8.45% compared to SPDR S&P 500 ETF (SPY) at 5.01%. This indicates that SBRA's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%AugustSeptemberOctoberNovemberDecember2025
8.45%
5.01%
SBRA
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab